KPL-387

· Kiniksa Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KPL-387, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Transition to KPL-387 Monotherapy Dosing & Administration Study [Phase 2]